HopeStage
Back to all studies
RecruitingNCT07489651

RE104 for generalized anxiety symptoms

About this titleRead the official source — NCT07489651

This study evaluates the safety and effectiveness of RE104 for Injection for people with anxiety.

Medication studyAges 18–74United States
The study in practice

Understand this study

What is this study about?

This study evaluates the safety and effectiveness of RE104 for Injection for people with anxiety.

Who could participate?

This study is for people with anxiety. Listed age limits: 18 years to 74 years. Other eligibility criteria apply.

Listed locations
Birmingham and 27 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 20, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
160
Sponsor
Reunion Neuroscience Inc
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 74 Years
Official registry ID
NCT07489651
Official title
Show the full official title

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Generalized Anxiety Disorder

Recruitment & locations

Currently recruiting

Birmingham · Gilbert · Little Rock

24 more locations
  • Garden Grove
  • La Jolla
  • San Francisco
  • Santa Monica
  • Lauderhill
  • Tampa
  • Atlanta
  • Decatur
  • Norcross
  • Savannah
  • Chicago
  • Novi
  • Saint Charles
  • Albuquerque
  • New York
  • Chapel Hill
  • North Canton
  • Portland
  • Philadelphia
  • West Chester
  • Austin
  • Plano
  • Draper
  • Orem

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study evaluates the safety and effectiveness of RE104 for Injection for people with anxiety.

Who is behind this study?

The study sponsor is Reunion Neuroscience Inc.

Does this study involve medication?

Yes. The study involves medication, including RE104 for Injection and Placebo.

Who can participate?

This study is for people with anxiety. Listed age limits: 18 years to 74 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies